Bio-Rad Laboratories Stock Price, News & Analysis

Bio-Rad Laboratories, Inc. is a renowned American company that specializes in developing and manufacturing advanced technological products for the life science research and clinical diagnostics sectors. Headquartered in Hercules, California, Bio-Rad offers a wide range of products and solutions tailored for clinical diagnostics and life sciences markets.

In the clinical diagnostics segment, which accounts for 56% of its sales, Bio-Rad provides test systems and specialized quality controls to clinical laboratories. On the other hand, in the life sciences segment (44% of sales), the company focuses on developing and manufacturing instruments and reagents utilized in research, biopharmaceutical production, and food testing. Bio-Rad holds a prominent position in dPCR technology, a key technology in the field.

Furthermore, Bio-Rad Laboratories boasts a diverse geographical presence, with significant market shares in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other regions (6%). Noteworthy is Bio-Rad's ownership of approximately 33% in Sartorius, a leading supplier in lab and bioprocessing equipment, particularly known for its single-use technology in biologics manufacturing.